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PknB is an essential serine/threonine protein kinase required for myco-
bacterial cell division and cell-wall biosynthesis. Here we demonstrate that
overexpression of the external PknB_PASTA domain in mycobacteria results
in delayed regrowth, accumulation of elongated bacteria and increased sensi-
tivity to b-lactam antibiotics. These changes are accompanied by altered
production of certain enzymes involved in cell-wall biosynthesis as revealed
by proteomics studies. The growth inhibition caused by overexpression of
the PknB_PASTA domain is completely abolished by enhanced concentration
of magnesium ions, but not muropeptides. Finally, we show that the addition
of recombinant PASTA domain could prevent regrowth of Mycobacterium
tuberculosis, and therefore offers an alternative opportunity to control replica-
tion of this pathogen. These results suggest that the PknB_PASTA domain is
involved in regulation of peptidoglycan biosynthesis and maintenance of
cell-wall architecture.1. Introduction
Serine/threonine protein kinases (STPKs) are widely distributed in Gram-
positive and Gram-negative bacteria [1].Mycobacterium tuberculosis, the causative
agent of tuberculosis, possesses 11 STPKs [2] and two of them, PknA and PknB,
are indispensable for growth in laboratory culture [3–5], while PknE [6], PknG
[7,8] and PknH [9] have been implicated inM. tuberculosis virulence. The essential
PknB kinase belongs to a distinct family of STPKs found only in Gram-positive
bacteria [10]. The important feature of these kinases is the presence of the
so-called PASTA (penicillin-binding protein and serine/threonine kinase
associated) domains in the surface-exposed region [11]. In Firmicutes, PASTA-
domain-containing kinases are not essential for growth. In Staphylococcus
aureus, an Stk1 mutant was impaired in virulence and had higher resistance to
Triton X-100 and fosmidomycin [12], while in S. pneumoniae StkP kinase was
important for competence, biofilm formation and virulence [13]. More detailed
investigation of the role of StkP in S. pneumoniae established that it has a crucial
role in coordinating cell division and peptidoglycan synthesis during growth
[14]. By contrast, PrkC in Bacillus subtiliswas shown to be important for survival
in stationary phase. A prkC deletionmutant had a significantly lower optical den-
sity in stationary phase compared with the wild-type bacilli [15]. However, in
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Figure 1. Schematic representation of PknB constructs and strains generated in this study. Kinase, N-terminal kinase domain (aa 1–279); TM, transmembrane
region (aa 331–354); TM-PASTA, penicillin and serine or threonine kinase-associated domain (aa 331–627); MYC-HIS, His-Tag; PASTA (aa 354–627).
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muropeptide-mediated germination pathway [16] and poss-
ibly remodelling of the cell wall via controlling expression of
YocH muralytic enzyme [17].
In Streptomyces coelicolor, a PASTA domain containing
kinase PknB regulates carbon flux and antibiotic pro-
duction, and is not essential for growth [18]. In
Corynebacterium glutamicum, PknB is also dispensable for
growth, and a significant change in replication and cell
shape could only be detected in mutants missing several
STPKs [19]. In this bacterium, PknB apparently regulates
polymerization of FtsZ; however, the precise mechanism
and biological significance of this observation require
further investigation.
Mycobacteria appear to be a unique bacterial group in
which PknB is essential for growth [3–5]. Its overexpression
or partial depletion in M. smegmatis and M. bovis BCG
caused dramatic alterations of cellular morphology and
growth inhibition; the enzymatic activity of PknB was
demonstrated to be essential for the observed effects [4,5].
Over the past decade, great progress has been achieved in
the identification of PknB substrates [10]. They include pro-
teins from various functional categories: cell-wall
enzymes—InhA [20], PbpA [21] and MabA [22]; regulatory
proteins—SigH [23], GarA [24] and FhaA [25]; and proteins
involved in cell division—Wag31 [4] and MviN [26]. Also,
PknB regulates an ‘oxygen-mediated replication switch’,and hence transition to dormancy and resuscitation [27].
Therefore, it is not surprising that PknB has been considered
as a critical drug target for development of anti-tuberculosis
antimicrobials. Possible application of PknB kinase inhibitors
for killing of M. tuberculosis was investigated. Yet only
limited success has been achieved, mainly because of poor
penetration of these agents into mycobacterial cells [28].
PknB consists of several domains (figure 1); functions for
some of them have been established, while the precise role of
others remains unknown [29]. The components of PknB
include a conserved catalytic kinase domain, a juxtamem-
brane part attached to a membrane-spanning region and
surface-exposed sensory component, consisting of PASTA,
designated as PknB_PASTA domain [30,31]. PASTA domains
have been proposed to recognize growing strands of nascent
peptidoglycan and activate STPKs. Structural studies showed
that B. subtilis PASTA domain binds synthetic muropeptides
at relatively high affinity, with the presence of the diaminopi-
melic acid in the muropeptide being crucial for this binding
[32]. The PknB_PASTA domain from mycobacteria can also
bind synthetic muropeptides; however, it remains unclear
whether this binding influences activation of PknB, bacterial
growth and resuscitation [33].
In this study, we investigated whether the extracellular
PknB_PASTA domain itself plays a distinct role in mycobacter-
ial growth, and therefore can be potentially used as a drug
target or a novel chemotherapeutic agent. The results presented
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growing peptidoglycan strands, and regulates production of
penicillin-binding proteins and distribution of proteins
involved in division and generation of septum. Furthermore,
our data indicate that the interactions of the PknB_PASTA
domainwith the cell wall are important, and that its abundance
mayserve as a controllingmechanism for the integrity of the cell
wall and bacterial growth.hing.org
Open
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2.1. Bacterial strains and growth media
Mycobacterium smegmatis mc2155, M. bovis BCG Glaxo strain
and M. tuberculosis H37Rv were grown in Sauton’s medium or
Middlebrook 7H9 (Becton, Dickinson and Company) medium
supplemented with Albumin-Dextrose Complex (designated as
supplemented 7H9 medium). M. smegmatis was also grown in
Lysogeny broth (LB) with addition of 0.05% (w/v) Tween 80
to prevent bacterial aggregation. All bacterial strains were culti-
vated at 378C with shaking in BD Falcon conical tubes or in
conical flasks. Where needed, antimicrobials were added at the
following concentrations (mg ml21): hygromycin 50; kanamycin
50; tetracycline 0.02.
Bacterial growth was followed by measurement of absor-
bance at 580 nm in a Jenway spectrophotometer. Growth of
M. smegmatis in variousmediawas performedusing a Bioscreen
Growth Analyser as described previously [34]. Presented Bio-
screen data are mean values of two independent experiments
done in quintuplicate. Three independent transformants were
used for all growth experiments. Viability was assayed by esti-
mation of colony-forming unit (CFU) on 7H10 agar (Becton,
Dickinson and Company). Supernatants were prepared from
logarithmic phase cultures ofM. tuberculosis (OD580 ¼ 0.6–0.8)
grown in Sauton’s medium, filter sterilized twice and used
for experiments immediately. For dose-dependencyexperiments
culture supernatants were freeze-dried and reconstituted
in sterile water. For low-magnesium control experiments
concentration of MgSO4 in Sauton’s medium was 0.2 mM.
2.2. Microscopy
Mycobacterium smegmatis bacilli were mounted on PBS and
observed by phase contrast microscopy using a Diphot 300
inverted microscope with a 100 W mercury light source.
Images were recorded using a 12/10 bit, high-speed Peltier-
cooled CCD camera (FDI, Photonic Science) using IMAGE-PRO
PLUS (MediaCybernetics) software. Labelling of nascent peptido-
glycan was done as described previously [35]. Briefly,
mycobacteria were grown in Sauton’s medium in the presence
of 20 ng ml21 of tetracycline to exponential growth phase
(OD600 0.5). Amixture of Vancomycin-BODIPY (Life Technol-
ogies) andunlabelledvancomycin (1 : 1)was added to cultures to
the final concentration of 2 mg ml21, followed bya 2 h incubation
at 378C with shaking. Bacteria were washed twice with PBS
containing 0.1%Tween 80 andused for fluorescencemicroscopy.
2.3. Generation PknB constructs for overexpression
studies
The pknB gene and its variants (electronic supplementary
material, table S1) were amplified from M. tuberculosis H37RvDNA and cloned into the BamHI and SpeI sites of the pMind
plasmid [36] (fordetails ofprimers see electronic supplementary
material, table S2). Constructs were confirmed by sequencing
and electroporated into M. smegmatis or M. tuberculosis. Over-
expression of pknB or its variants was induced by the addition
of tetracycline and confirmed by qRT-PCR.
2.4. Preparation of muropeptides
Peptidoglycan from Escherichia coli and mycobacteria was iso-
lated and purified as described previously [37,38]. For growth
assays peptidoglycan (2 mg) was digested with mutanolysin,
lysozyme, RpfB or MltA at 378C for up to 72 h. Muramidases
were used at the final concentration of 100 mg ml21. Peptido-
glycan digestion with mutanolysin and MltA was carried out
in buffer containing 80 mM NaH2PO4, pH 4.8; with lysozyme
in 25 mMNaH2PO4, pH 6.0; and with RpfB in 40 mM sodium
citrate, pH 6.5. The presence of muropeptides was confirmed
by HPLC. In separate experiments, peptidoglycan was soni-
cated three times for 30 s, briefly spun down at 100g to
remove big fragments and used for growth assays. Synthetic
muropeptides were prepared as described previously [39].
2.5. Determination of minimum inhibitory
concentration for selected antimicrobials
Tests were performed in 96-well microtitre plates using a
dilution method [40]. Briefly, M. smegmatis (1  105 CFU)
was inoculated in 100 ml of Sauton’s medium supplemented
with kanamycin and tetracycline, and a range of concentrations
of antimicrobial tested. Plates were incubated for three days at
378C. MIC was determined as the lowest concentration at
which no visible growth was detected after 3 days of incu-
bation. Fresh antimicrobial stocks were prepared for each
experiment; four independent experiments were done.
2.6. Effect of recombinant PASTA protein on growth
of Mycobacterium tuberculosis
Recombinant PASTAwas purified as described previously [31]
and filter sterilized prior to growth experiments. Mycobacteria
(103 cells ml21) were inoculated in 16-well microtitre plates
containing supplemented 7H9 medium with different concen-
tration of sterile rPknB_PASTA. For each concentration four
replicates were inoculated. Sealed plates were incubated at
378C without shaking. Optical density was measured after 15
and 25 days of incubation. The experiment was repeated
twice. Similar results were obtained when mycobacteria were
grown in Falcon tubes or conical plastic flasks. M. tuberculosis
stationary phase culture was stored at 48C for two months
and 2  104 cells ml21 were inoculated in conical flasks. The
flasks were incubated at 378C for up to 12 weeks. Optical
density was measured at regular intervals using a Jenway
spectrophotometer. The assay was performed in triplicate,
three times.
2.7. Transcriptional profiling
Total RNA was isolated from 10 ml of mycobacterial cultures
from exponential growth phase using the TRIzol method
[41]. DNA contamination was removed with Turbo DNA-
free DNAase (Ambion) before cDNA was generated using
rsob.royalsocietypublishing.org
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specific primers (electronic supplementary material, table S2).
Q-PCR was performed in a Corbett Rotor Gene 6000 real-
time thermocycler using Absolute QPCR SYBR Green mix
(Thermo) and gene-specific primers. Levels of expression
were normalized to 16 s rRNA [42].
2.8. Protein electrophoresis and Western blot
Mycobacteria were collected by centrifugation, washed in PBS
and resuspended in buffer containing 50 mM Tris–HCl, pH
8.0 and 150 mM NaCl. Bacteria were lysed in FastPrep-24
Instrument (MP Biomedicals, UK) using glass beads. Lysates
were centrifuged at 14 000g for 20 min to separate soluble and
insoluble fractions. Proteins were separated, using 12% SDS
PAGE and transferred on nitrocellulose membrane. Primary
antibodies were anti-polyhistidine antibodies (Sigma); alka-
line-phosphatase conjugate anti-mouse antibodies were used
as secondary antibodies. Sigma Fast BCIP/NBT was used as a
substrate to visualize recognized proteins.
2.9. Isolation of membrane protein fraction
for proteomics analysis
Membrane fractions were prepared as described previously
[43]. Briefly,M. smegmatis TMP and MIND strains were inocu-
lated in 2 l conical flasks containing 500 ml Sauton’s medium.
The cultures were incubated at 378C with shaking (200 r.p.m.)
for 3 h. Cultures from two flasks were used for preparation of
membrane fractions of each strain. The bacteriawere harvested
by centrifugation at 6000g for 20 min and washed with PBS.
The pellets were resuspended in 10 ml of extraction buffer con-
taining 50 mMTris–HCl, pH8.0, 150 mMNaCl, 10 mMMgCl2
and stirred on ice for 10 min. The cell suspensionwas sonicated
before adding 100 mg of DNase I per gram of cells and stirring
on ice for 5 min to decrease viscosity. The suspension was cen-
trifuged at 25 000g for 25 min at 48C. The pellet was discarded
and the supernatant centrifuged at 100 000g for 60 min at 48C.
After discarding supernatant the pellet was carefully resus-
pended in 100 mM sodium carbonate buffer, pH 11.5 and
centrifuged at 100 000g for 60 min. The centrifugation
and resuspension in carbonate buffer steps were repeated a
minimum of three times before a final resuspension and cen-
trifugation step using sterile MilliQ water. The membrane
fractions were resuspended in 1 ml sterile deionized water
and freeze-dried.
2.10. Analysis of membrane proteins
Proteomics was carried out by the University of Leicester
Proteomics Facility (PNACL, University of Leicester, http://
www2.le.ac.uk/colleges/medbiopsych/facilities-and-services/
cbs/protein-and-dna-facility/pnacl). Trypsin digestion ofmem-
brane proteins was performed using a filter-aided sample
preparation method [44]. LC–MS/MS was carried out using
an RSLCnano HPLC system (Dionex, UK) and an LTQ-
Orbitrap-Velos mass spectrometer (Thermo Scientific). Peptides
were eluted from the trap column at a flow rate of 0.3 ml min21
and through a reverse-phase PicoFrit capillary column (75 mm
i.d.  400 mm) containing Symmetry C18 100 A˚ media
(Waters, UK) that was packed in-house using a high-pressure
device (Proxeon Biosystems, Denmark) over a period of 4 h,with the output of the column sprayed directly into the nano-
spray ion source of the LTQ-Orbitrap-Velos mass spectrometer.
The raw data file obtained from each LC–MS/MS acqui-
sition was processed using Proteome DISCOVERER (v. 1.4.0.288,
Thermo Scientific), searching each file in turn using MASCOT
[45] (v. 2.2.04, Matrix Science) against the UniProtKB-
Swissprot database. The peptide tolerance was set to
10 ppm and the MS/MS tolerance was set to 0.02 Da. Fixed
modifications were set as carbamidomethyl (C) and variable
modifications set as oxidation (M). A decoy database search
was performed. The output from Proteome DISCOVERER was
further processed using SCAFFOLD Q þ S4 (v. 4.0.5, Proteome
Software, Portland, OR, USA). For quantitative experiments
the digested peptides were labelled with the TMTsixplex
Label Reagent kit (Life Sciences) according to the manufac-
turer’s instructions. SCAFFOLD Qþ (v. 4.3.4, Proteome
Software) was used to quantify Label Based Quantitation
(iTRAQ, TMT, SILAC) peptide and protein identifications.
Both protein and peptide identifications were accepted if
they could be established at greater than 95.0% probability
and contained at least two identified peptides. Peptide prob-
abilities from X! Tandem were assigned by the Peptide
Prophet algorithm [46] with SCAFFOLD delta-mass correction.
Peptide probabilities from MASCOT were assigned by the
SCAFFOLD Local FDR algorithm. The mass spectrometry pro-
teomics data have been deposited to the ProteomeXchange
Consortium via the PRIDE partner repository with the
dataset identifiers PXD002120 and 10.6019/PXD002120.
2.11. Analytical gel-filtration
Fifty microlitres of PknB_PASTA at a concentration of 50 mM
were injected on a S75 10/300 column (GE Life Science) at a
0.4 ml min21 flow rate. The column was equilibrated with
25 mM Tris–HCl (pH 8.5), and 100 mMNaCl with or without
25 mM MgSO4. For the injection in the column in the buffer
without MgSO4, the protein was pre-incubated with 5 mM
EDTA. In the case of gel-filtration in the presence of MgSO4,
the protein was pre-incubated with 25 mM MgSO4.
2.12. Nuclear magnetic resonance experiments
All nuclear magnetic resonance (NMR) experiments were
carried out at 208C on Bruker Avance III 700 (1H–15N double
resonance experiments) or Avance III 500 (1H–13C–15N
triple-resonance experiments) spectrometers equipped with
5 mm z-gradient TCI cryoprobe, using the standard pulse
sequences. NMR samples consist of approximately 50 mM
15N-labelled protein dissolved in 10 mM phosphate buffer
(pH 6.8), 100 mM NaCl, with 5% D2O for the lock prepared
as described elsewhere [31].3. Results
3.1. The external PASTA domain is important
for PknB function
It has been previously shown that overexpression of enzy-
matically active PknB in mycobacteria results in growth
inhibition and alteration of bacterial shape [4]. Additionally,
the external PknB_PASTA domain is indispensable for func-
tional complementation of PknB conditional mutants of
(a)
(b)
(c)
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Figure 2. Effect of pknB and pknB-DPASTA overexpression on growth of
M. smegmatis. Mycobacteria (5  106) from early stationary phase were
inoculated in 100-well honeycomb plates, containing various media and incu-
bated in Bioscreen Growth analyser at 378C with shaking for 5 days in the
presence of tetracycline. Presented data are mean values of 5 replicates from
two independent experiments. Standard deviations were 10% or less of
average values and are not shown for clarity.
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role of the PknB_PASTA domain in regulation of mycobacter-
ial growth and peptidoglycan biosynthesis remains unclear.
In our initial experiments, we investigated growth patterns
of M. smegmatis overexpressing pknB.
A full-length pknB or its truncated form missing the region
encoding the external PASTA domain (pknB-DPASTA) was
cloned into pMind plasmid [36], containing a tetracycline-regu-
lated promoter (figure 1; electronic supplementary material,
table S1). The plasmids were transformed into M. smegmatis
and the resultant strains, designated as PknB1 (pknB), PknB5
(pknB-DPASTA) and MIND (empty plasmid), grew similarly in
all media tested in the absence of the inducer tetracycline (data
not shown). However, addition of tetracycline to the PknB1 or
PknB5 strains affected growth in liquid medium (figure 2).
This inhibitory effect was probably caused by the induction of
expression of pknB and pknB-DPASTA from the pMind plasmid.
When grown in the presence of tetracycline, PknB1 and PknB5
expressed the pknB versions from pMind at relatively high
level, corresponding to 1% (+0.3%) of all 16s-rRNA transcripts
as judged by quantitative RT-PCR; no expression of the target
genewas detected inmycobacteria in the absence of tetracycline.
Interestingly, overexpressing the pknB versions resulted in
different growth characteristics. In all media, the PknB1 strain
had a longer apparent lag phase (time to detectable turbidity)
and slower growth rate (figure 2; electronic supplementary
material, table S3), indicating that overexpression of the trun-
cated PknB missing the external PASTA domain was less toxic
than overexpression of the full-length kinase.
To further investigate the role of the PknB_PASTA domain
in bacterial growth directly,we cloned the pknB region encoding
the membrane-anchored external domain of M. tuberculosis
(designated as tmp, figure 1) into the pMind plasmid and
transformed this plasmid into M. smegmatis. In the absence of
tetracycline, both MIND and TMP strains grew similarly
(figure 3a, filled symbols) and their cDNA analysed by q-RT-
PCR contained similar levels of tmp transcripts. However,
addition of tetracycline led to overexpression of the tmp
transcript (reaching 9.6+0.8% from the total 16 s rRNA tran-
scripts) in the TMP strain, which resulted in growth inhibition,
especially in Sauton’s medium (electronic supplementary
material, table S3; figure 3a, open symbols). The TMP strain
required a longer time to initiate bacterial growth, but its
growth ratewas identical to the one observed in theMIND con-
trol strain. This phenotypewas highly reproducible and did not
changeafterpassage in vitro (electronic supplementarymaterial,
figure S1). Expression of the PASTA domain without the trans-
membrane domain (PknB13), the transmembrane domain on its
own (PknB9) or the transmembrane domain with one PASTA
unit (PknB10; figure 1) had no significant effect on bacterial
growth (figure 3b). Strains overexpressing the PASTA domain
with two or three PASTA units (PknB11 and PknB12, respect-
ively) displayed a marginal growth defect. All PASTA variants
were expressed at similar levels according to qRT-PCR
(data not shown). We generated Myc-6xHis-tagged versions of
TMP (designated as TMPH strain; electronic supplementary
material, table S1) and of the soluble PASTA domain (desig-
nated as PknB14) and investigated their localization by
western blot. TMPH was detected in the envelope fraction,
while PknB14 was found in the cytoplasm M. smegmatis
(figure 3c,d). Importantly, TMPH and TMP strains showed no
difference in growth under all conditions described here (data
not shown). These results confirm that only the surface-exposeddomain containing four PASTA units significantly impaired
mycobacterial growth.
Overproduction of the PknB_PASTA domain also influ-
enced cellular morphology. Microscopic examination of the
strains revealed accumulation of elongated TMP cells of irregu-
lar shape (figure 4b, left panel), similar to cells with partially
depleted PknB [4], suggesting that the overexpressed PASTA
domain possibly interfered with the PknB function. Further-
more, Vancomycin-BODIPY labelling revealed anomalous
distribution of nascent peptidoglycan in TMP mycobacteria
(figure 4b, middle panel). While in control MIND cells newly
synthesized peptidoglycan was mainly localized at the poles
andmid-cell (figure 4a), TMP cells displayed a diffused staining
across the entire cell surface (figure 4b).Wealsoobservedsignifi-
cant proportions of unlabelled or weakly labelled TMP cells
(figure 4b). TMP mycobacteria tend to aggregate, suggesting a
modified cell surface, delayed cell separation or increased lysis.
3.2. Elevated Mg2þ ion level eliminates TMP-mediated
growth inhibition
The results described above support the functional importance
of the PknB_PASTA domain for PknB activity. The structural
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Figure 3. Effect of PknB_PASTA overexpression on M. smegmatis growth. (a) Comparative growth kinetics of M. smegmatis strains in Sauton’s medium. The same inocu-
lum (approx. 2  106 cells per well) was used to seed induced (þtetracycline) and control cultures, respectively. (b) Overexpression of non-secreted PASTA domains or
transmembrane domain on its own does not affect mycobacterial growth. (c) Detection of PknB_TM-PASTA-6  HIS in membrane fraction of M. smegmatis strains by
western blotting. (d ) Detection of the PASTA domain missing the transmembrane region in cytoplasmic fraction of M. smegmatis strains by Western blotting.
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dimerize beacuse of conformational flexibility between the
different PASTA domains [31]. It was proposed that the bind-
ing of putative ligands could induce the dimerization of
kinase domains and consequent trans-activation of PknB [31].
Thus, the PASTA domain could serve as a receptor for signal-
ling molecules (e.g. muropeptides) and activate bacterial
resuscitation and growth, employing the mechanism pre-
viously proposed for B. subtilis spore germination [16,39].
The PknB_PASTA domain missing the functional kinase
domain may compete with the native PknB for the ligands
and dysregulate the PknB-mediated signalling pathways.
Therefore, we investigated whether culture supernatant from
growing mycobacteria (potentially containing the putative
ligand) would eliminate the growth defect caused by TMP
overexpression. Indeed, the growth inhibition was abolished
by the addition of culture supernatant in a dose-dependent
manner (figure 5a). Further tests showed that the active
compound was a low-molecular-weight chemical resistant
to heating and it was present in Sauton’s medium prior toexposure to bacteria (data not shown). Eventually, we demon-
strated that the active entity was Mg2þ from MgSO4 or MgCl2.
Elevated concentration of Mg2þ could completely abolish the
inhibition by PASTA-domain overexpression (figure 5b) and
the dose-dependent effect of conditioned medium was largely
because of increased Mg2þ concentrations (data not shown).
Supernatants obtained from cultures grown in lower-MgSO4
(0.2 mM) medium had only a moderate growth-stimulatory
effect on both control and TMP strains (figure 5c). The increa-
sed Mg2þ concentration did not influence expression of tmp
(p. 0.05, t-test) and the production of TMPH, aHis-tagged ver-
sion of TM-PASTA (data not shown).Magnesiumalso improved
growth of PknB1 and PknB5 strains (data not shown).
To investigate whether the PknB_PASTA domain was
able to bind Mg2þ ions, we used NMR methodology [31].
A 15N-labelled sample of recombinant PknB_PASTA (50 mM)
was titrated with increasing amounts of MgCl2 (or MgSO4)
up to 50 mM. The ion binding with either a lateral chain or
the protein backbone would generate chemical-shift pertur-
bation on the 1H–15N resonance measured in the HSQC
(a)
(b)
Figure 4. Overexpression of PknB_PASTA results in alteration of bacterial mor-
phology and vancomycin labelling. Mycobacteria from logarithmic growth phase
were labelled with Vancomycin-BODIPY conjugate, washed and mounted in PBS
and examined using a Diphot 300 inverted microscope. Three independent fields
for each strain are shown. Bars indicate 5 mm. (a) MIND and (b) TMP. Left panel,
phase contrast; middle panel, fluorescence microscopy; right panel, merged
images. Arrows indicate labelled peptidoglycan.
rsob.royalsocietypublishing.org
Open
Biol.5:150025
7
 on May 19, 2016http://rsob.royalsocietypublishing.org/Downloaded from experiment [48]. However, no chemical-shift perturbation was
observed in the PknB_PASTA upon addition of MgCl2 or
EDTA, suggesting a lack of interaction between the protein
and Mg2þ ions (electronic supplementary material, figure S2),
and the addition of MgSO4 to recombinant PASTA did not
change the oligomerization state of recombinant PASTA (elec-
tronic supplementary material, figure S3). These results show
that the ameliorating effect of Mg2þ on TMP-mediated
growth inhibition was indirect.
3.3. Muropeptides do not eliminate TMP-mediated
growth inhibition
In separate experiments, we tested the effects of muropeptides
on the growth inhibition in the TMP strain.Weusedpeptidogly-
can from E. coli digested with various muramidases, sonicatedor RpfB-digested peptidoglycan from M. smegmatis, and syn-
thetic muropeptides, N-acetylglucosamine, N-acetylmuramic
acid and N-acetylglucosaminyl–N-acetylmuramic acid (elec-
tronic supplementary material, table S4). We only observed a
minor reduction in the duration of lag phase of TMP strain
from 65 to 52 h in the presence of relatively high concentrations
of digested or sonicated peptidoglycan (0.5 mg ml21 and
higher). The observed reduction in lag phase did not depend
on the type of peptidoglycan used. Synthetic muropeptides,
previously employed for germination of B. subtilis spores [39],
did not reduce growth inhibition at any concentration tested
(10 pM–50 mM) and did not stimulate growth of
M. smegmatis (figure 5d). Among other divalent metals tested
Ca2þ improved the TMP growth; however, it could not be
used at concentrations above 5 mM because of poor solubility.
Since Mg2þ ions are known to stabilize the cell wall and are
frequently used for cultivation of bacteria with defective cell
walls [49], we investigated whether the TMP strain was more
susceptible to various antimicrobials compared with control.3.4. Overexpression of PknB-PASTA increases sensitivity
of Mycobacterium smegmatis to b-lactam
antibiotics and alters the abundance of
cell-wall proteins
We testedminimum inhibitory concentrations (MIC) of various
antimicrobial agents for PknB1, TMPandMIND strains.MICof
rifampicin (inhibition of transcription), ethambutol (arabinoga-
lactan biosynthesis) and streptomycin (protein biosynthesis)
were identical in all the strains tested (table 1). However,
the TMP strain was remarkably more sensitive to several
b-lactam antibiotics: meropenem, ampicillin and clavulanate,
an inhibitor of b-lactamase. In the presence of sub-inhibitory
concentration of clavulanate (100 mM), MIC of meropenem for
the TMP strain decreased below 0.15 mM compared with
6.5 mM in the control strain. Interestingly, overexpression of
PknB did not alter antimicrobial susceptibility, suggesting
that the PknB-PASTA domain on its ownmay perturb peptido-
glycan synthesis, causing higher sensitivity to b-lactams. The
perturbation of peptidoglycan synthesis could also explain
the prolonged lag phase observed in the TMP strain. To address
this possibility, membrane proteins isolated from the MIND
and TMP strains in lag phase were investigated.
In total, we identified 1071 proteins in the membrane
fractions of both strains using LTQ-Orbitrap-Velos mass spec-
trometry. The TMPH strain had 90 proteins specific for this
sample and 95 proteins were detected in the MIND strain
only. The majority of proteins (886) were identified in both
strains. Importantly, production of the PknB_PASTA domain
in the membrane fraction was confirmed by detection of 22
unique fragments with 86% peptide coverage in the TMPH
strain (electronic supplementary material, table S5). Most of
the proteins detected (705) were assigned as hypothetical with
unknown function, while 267 were predicted as membrane or
cell-surface proteins. This result confirms that the extraction
procedure selectively enriched the membrane proteins. A high
number of membrane proteins implicated in transport of
metals, nutrients and enzymes was found in the membrane
fractions of both strains. Next, peptides were labelled
using the TMPsixplex kit to compare the relative abundance
of membrane proteins in TMP and MIND (electronic
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Figure 5. Culture supernatant and high concentration of Mg2þ abolish the inhibitory effect caused by PknB-PASTA overexpression. (a) Culture supernatants abolish growth-
inhibitory effect of PknB_TM-PASTA overexpression in a dose-dependent manner. Relative concentration of culture supernatant added is expressed as ‘fold concentration’. A
value of onefold corresponds to undiluted culture supernatant. The apparent lag phase was calculated as a period of time when culture reached OD600 nm 0.1. (b) Mg
2þ
(10 mM) relieves growth inhibition of TMP in a manner comparable with undiluted culture supernatant. (c) Effect of low Mg2þ supernatant on apparent lag phase of TMP
strain. (d ) Effect of synthetic muropeptides on growth of M. smegmatis. Mycobacteria from early stationary phase were washed in Sauton’s medium twice and 5  106
bacteria were inoculated in Sauton’s medium, containing culture supernatant or synthetic muropeptides at final concentration of 10 mM. MPP, MurNAc-pentapeptide; DPP,
GlcNAc-MurNAc-peptapeptide; ADPP, GlcNAc-1,6 anhydromuramyl-pentapeptide; TPP, tetra-saccharide-peptide; SN, 50% (v/v) culture supernatant. GlcNAc, N-acetylgluco-
samine; MurNAc, N-acetylmuramic acid; pentapeptide, L-Ala-g-D-Glu-m-DAP-D-Ala-D-Ala. (b,d ) Presented data are mean values of 5 replicates from two independent
experiments. Standard deviations were 10% or less of average values and are not shown for clarity. SN, media were supplemented with culture supernatant.
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cell division proteins and enzymes involved in cell-wall bio-
synthesis. Most cell division proteins were equally present in
the TMP and MIND strains (data not shown). However,
CwsAwas more abundant in the TMP strain (table 2). The pre-
cise function of CwsA is unknown but it has been shown to
interact with CrgA, which is annotated as an inhibitor of
septum formation [50,51]. CrgAwas detected only in the mem-
brane fractions of TMP but not in those of MIND, and its
relative abundance could not be calculated. Another CrgA
interaction partner, Wag31, was detected at similar levels in
both strains. Interestingly, the TMP strain had more enzymes
involved in biosynthesis of mycolyl-arabinogalactan (table 2;
electronic supplementary material, table S5), including
several mycolyl- and galactofuranosyl-transferases. Regarding
peptidoglycan-related enzymes, the levels of two metallo-
b-lactamases, L,D-transpeptidase LdtB and D-alanyl-D-alanine
carboxypeptidaseDacB1,were increased in the TMPmembrane
fraction (table 2). Complete data are available via ProteomeX-
change with identifier PXD002120. Collectively these results
may suggest that the overexpression of the PASTA domain
influences the biosynthesis and architecture of mycobacterial
cell wall.3.5. The addition of recombinant PASTA protein
abolishes growth of Mycobacterium tuberculosis
The results described above suggest that overexpression of
the PknB_PASTA domain can be employed for growth inhi-
bition and increase of susceptibility to antimicrobials in
medically important pathogen M. tuberculosis. We therefore
investigated whether the PknB_PASTA domain would have
a similar effect in M. tuberculosis. We transformed pMind
pknB7 and empty pMind plasmids (electronic supplementary
material, table S1) into M. tuberculosis H37Rv and investi-
gated growth of the resultant strains (TMP and MIND) in
the presence of tetracycline. As shown in figure 6a, overex-
pression of the external membrane attached PASTA (TMP)
indeed inhibited initiation of M. tuberculosis growth. We
next studied if addition of recombinant PASTA protein con-
taining PASTA units only (residues 354–626, designated as
rPASTA) may alter the growth. We noted that the addition
of rPASTA to M. tuberculosis resulted in growth defect at con-
centration of 10 mg ml21 (figure 6b) and increased apparent
lag phase from 5 to 14 days. This growth inhibition was
temporary and the cultures eventually produced normal
growth, while addition of recombinant PASTA to logarithmic
Table 1. Effect of PknB-PASTA overexpression on antimicrobial susceptibility of M. smegmatis.
strain
minimum inhibitory concentration against antibiotic (mM)
rifampicin streptomycin ethambutol meropenem clavulanate meropenem1clavulanatea ampicillin
MIND 1.2 0.4 2.5 13–19.5 .1000 6.5–13.0 140–170
PknB1 1.2 0.4 2.5 13–19.5 .1000 6.5–13.0 140–170
TMP 1.2 0.4 2.5 6.5 150–200 0.13 30–45
aClavulanate was added at a concentration of 100 mM.
Table 2. Cell-wall enzymes and proteins differently abundant in TMP compared with MIND.
M. tuberculosis
protein
M. smegmatis
protein protein description
ratio TMP/MIND
log2-fold
Rv0014c MSMEG_0028 His-Tagged TM-PASTA 5.9
Rv0008c MSMEG_0023 cell-wall protein CwsA 1.0
Rv3804c MSMEG_6398 FbpA mycolyl transferase 1.0
Rv3790 MSMEG_6382 DprE1 decaprenylphosphoryl-b-D-ribose 20oxidase 0.9
Rv3577 MSMEG_6071 metallo-b-lactamase 0.9
Rv0129c MSMEG_3580 FbpB mycolyl transferase 0.6
Rv3782 MSMEG_6367 galactofuranosyl transferase 0.8
Rv3808c MSMEG_6403 galactofuranosyl transferase 0.8
Rv3265 MSMEG_1826 dTDP-RhA:a-D-GlcNAc-diphosphoryl polyprenol, a-3-L-rhamnosyl transferase 0.7
Rv0906 MSMEG_5638 metallo-b-lactamase 0.6
Rv2518c MSMEG_4745 LdtB L,D-transpeptidase 0.6
Rv0237 MSMEG_0361 glycosyl hydrolase 0.6
Rv3330 MSMEG_1661 DacB1D-alanyl-D-alanine carboxypeptidase 0.5
Rv2748c MSMEG_2690 DNA translocase FtsK 0.5
Rv2171 MSMEG_4239 conserved lipoprotein 20.8
Rv2721c MSMEG_2739 transmembrane alanine and glycine-rich protein 20.5
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However, the growth-inhibitory effect of rPASTA was more
pronounced in experiments when mycobacteria were stored
at 48C for two months (figure 6c). We found that these cells
retained culturability and produced normal growth both in
liquid and solid media. Nevertheless, their growth initiation
was significantly delayed by addition of rPASTA at concen-
tration 10 mg ml21. The mycobacteria were not killed by
rPASTA and after two-month incubation generated normal
stationary phase culture (figure 6c). In all experiments, control
buffer did not have any inhibitory effect. These results suggest
that the PASTA domain may directly interfere with myco-
bacterial regrowth and, therefore, presents a plausible target
for the design of specific drugs altering bacterial regrowth
and resuscitation.4. Discussion and conclusion
PknB has been shown to regulate bacterial division, growth
and cell-wall biosynthesis [10]. The data presented in this
study suggest that the PknB-mediated signalling pathway
can be targeted through the external PknB_PASTAdomain. Overexpression of the PknB_PASTA domain
delayed the regrowth of both M. tuberculosis and M. smegma-
tis. The growth inhibition was ameliorated by addition of
high concentrations of Mg2þ but not by muropeptides.
Mg2þ ions are crucial for all living organisms, and the con-
centration may vary, reaching as high as 20 mM in
eukaryotic [52] and a massive 100 mM in prokaryotic cells
[53]. In Gram-negative bacteria magnesium ions stabilize
the outer membrane [54] and are found in high concen-
trations in the cell wall of Gram-positive bacteria, which
bind divalent ions to their teichoic acids [54]. Mycobacteria
do not possess teichoic acids and the binding of Mgþ2 ions
has not been studied in the mycobacterial cell wall in detail,
although Mg2þ ions improved growth of mycobacteria in
media with low pH [55]. Growth of B. subtilis mutants miss-
ing certain peptidoglycan binding proteins was improved at
high Mg2þ levels, suggesting that divalent metals may com-
pensate growth defects due to altered peptidoglycan
biosynthesis [56].
The precise mechanism of the magnesium effect on
growth of the TMP strain is unknown. Mg2þ ions may stabil-
ize the cellular membrane and protein complexes associated
with the membrane disturbed by overexpression of
(a) (b)
(c)
0
0.1
0.2
0.3
0.4
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Figure 6. PknB_PASTA reduces growth of Mycobacterium tuberculosis. (a) Overexpression of PknB_PASTA domain delays growth initiation. Mycobacteria (approx.
1  106) were inoculated in supplemented 7H9 medium containing hygromycin and tetrocycline. (b) Effect of different concentrations of rPASTA on M. tuberculosis
growth. Mycobacteria (103 cells ml21) were inoculated in supplemented 7H9 medium containing different concentration of sterile rPASTA. The optical density was
measured after 21 days of incubation. (c) Regrowth of stored M. tuberculosis was delayed by the addition of rPASTA. M. tuberculosis (2  104 cells ml21) was
inoculated in supplemented 7H9 medium. Buffer was used as control and rPASTA was added at final concentration of 10 mg ml21. (b,c) Each data point is
an average value of 3 biological replicates, error bars indicate standard deviations. Experiments were performed three times and results of one typical experiment
are shown.
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Mg2þ ions directly bind to the growing strands of stems of
peptidoglycan and promotes their polymerization. Further
dissection of molecular mechanisms underlying the inhibi-
tory effect of PknB_PASTA overexpression will facilitate
our understanding of the biological function of PknB and
its extracellular domain, as well as the roles of Mg2þ ions in
cell-wall architecture. Three possible scenarios may explain
the observed effects associated with overexpression of
PknB_PASTA (figure 7). (i) The overexpressed PknB_PASTA
competes for the ligand (peptidoglycan) with a native PknB,
and therefore interferes with the PknB-mediated signall-
ing pathway (figure 7a). (ii) The PknB_PASTA domain
interacts with penicillin-binding proteins and dysregulates
peptidoglycan biosynthesis (figure 7b). (iii) Finally, highly
abundant PknB_PASTA may directly disrupt the structure
of peptidoglycan by binding to the growing strand, and
physically prevent extension and cross-linking (figure 7c).
The regulatory function of PknB (phosphorylation of
cell-wall enzymes anddivision factors) is evolved to coordinate
cell-wall biosynthesis and division. In fact, a recently publi-
shed study established that PknB coordinated assembly of
peptidoglycan synthesizing complex via recruiting FhaA andphosphorylating MviN, a protein essential for mycobacterial
growth [26].
In Listeria monocytogenes the inactivation of a PASTA-
containing kinase, a homologue of PknB, resulted in increased
susceptibility to b-lactam antimicrobials [57], as in the TMP
strain, which presumably shows high susceptibility to
b-lactam antimicrobials because of partial inactivation of PknB
function. However, while the PknB mutant lyses and is not
able to grow, the TMP strain only shows an initial impairment
of growth in the form of a prolonged lag phase, but is able to
grow normally in exponential phase. Thus, other factors apart
from interference with PknB function may contribute to the
growth phenotype of the TMP strain.
A possible direct interaction of PknB_PASTA with penicil-
lin-binding proteins is in accordance with recent findings that
the PASTA domain of StkP kinase from S. pneumoniae was
able to bind penicillin-binding protein 2 [58]. We also
cannot exclude that the PASTA domain changes the architec-
ture of the cell wall by interacting directly with peptidoglycan
(figure 7c), as was previously observed in vitro [16,59]. The
results presented in this study may suggest that the over-
expressed PknB_PASTA domain interacts with growing
strands of peptidoglycan and possibly physically interferes
PGS
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P P
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Figure 7. Schematic representation of possible mechanisms of PknB_PASTA-
mediated growth inhibition. (a) In the TMP strain the overexpressed
PknB_PASTA competes with native PknB for peptidoglycan ligands and inter-
feres with PknB-mediated signalling. (b) Overexpressed PknB_PASTA binds
penicillin-binding proteins and dysregulates peptidoglycan polymerization.
(c) Overexpressed PknB_PASTA binds to peptidoglycan and destabilizes its
structure. PGS, peptidoglycan synthesis complex.
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susceptibility of the overexpressing strain tomeropenem, clavu-
lanate and ampicillin. Meropenem has been shown to inhibit
both DD-carboxypeptidase and LD-transpeptidase activities
[60], and in combination with clavulanate it is highly active
against growing and persisting mycobacteria [61].Our findings are consistent with the previously proposed
peptidoglycan-sensing role of PknB_PASTA [11,30]. Further
investigation is required to clarify whether the PknB_PASTA
domain recognizes the specific structures present in the region
of peptidoglycan growth and therefore activates dimerization
of the catalytic domains, or whether it plays a more structural
role in supporting growing peptidoglycan and ensuring proper
localization of PknB. Strains overexpressing truncated forms of
the PASTA domain did not have pronounced growth defect
(figure 3b), suggesting that four PASTA units and the transmem-
brane region are required for PknB functionality. Removal of the
transmembrane part resulted in mislocalization of the PASTA
domain. Although the precise role of the individual PASTA
units awaits elucidation, ourdataare consistentwith theprevious
observation that the truncated PknBmissing one ormore PASTA
domains was not able to complement the conditional pknB
mutant [47]. It is also remains unclear whether the PASTA
domain can sense short muropeptides released by mycobacteria
during growth. In our experiments, we obtained a very modest
effect of peptidoglycan on the growth inhibition caused by
PASTA overproduction and no stimulation of growth or resusci-
tation by externally added muropeptides. It is possible that
specific muropeptides are required for activation of PknB and
subsequent resuscitation, as muropeptides have been shown to
possess resuscitation-stimulatory activity [62]. It is conceivable
that the PASTAdomainmay be directly involved in resuscitation
by sensing in vivo rearrangement of peptidoglycan, possibly
because of the action of resuscitation-promoting factors [34,63]
and othermuramidases, and regulation of cell-wall biosynthesis.
Additional experiments on monitoring rearrangement of pepti-
doglycan and interaction between the external PASTA domain
and stem peptidoglycan, using solid-state NMR [64] and
probes for microscopy of living bacteria such as highly sensitive
atomic forcemicroscopy cantilevers [65]will allowus to establish
the precise PknB-mediated sensing mechanism.
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